Meda AB Acquires OTC Products in the US
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regualtory News: Meda has acquired three well established Over-The-Counter consumer products in the US from GlaxoSmithKline LLC (“GSK”). Total annual sales for the products are about 100 MSEK, with strong profit margins. The purchase price was 235 MSEK.